Literature DB >> 1530650

Binding specificity of lung surfactant protein SP-D for glucosylceramide.

Y Kuroki1, S Gasa, Y Ogasawara, M Shiratori, A Makita, T Akino.   

Abstract

The specificities of the binding of lung surfactant protein SP-D to glycolipids were examined using 125I-labeled SP-D as a probe. When the binding study was performed on TLC plates, SP-D bound exclusively to GlcCer, whereas it failed to bind to GalCer, GM1, GM2, asialo-GM1, asialo-GM2, sulfatide, Forssman antigen, ceramide dihexoside, ceramide trihexoside, globoside, paragloboside or ceramide. Excess native SP-D competed with 125I-SP-D for the binding to GlcCer. Antibody to rat SP-D inhibited 125I-SP-D binding to GlcCer. Ca2+ was absolutely required for the binding of SP-D to GlcCer; Mg2+ failed to substitute for Ca2+. SP-D bound to ceramide monohexoside in glycolipids isolated from rat lung and bronchoalveolar lavage fluids of rats.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530650     DOI: 10.1016/0006-291x(92)91291-w

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D.

Authors:  U Holmskov; J Mollenhauer; J Madsen; L Vitved; J Gronlund; I Tornoe; A Kliem; K B Reid; A Poustka; K Skjodt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

2.  Rat mannose-binding protein a binds CD14.

Authors:  H Chiba; H Sano; D Iwaki; S Murakami; H Mitsuzawa; T Takahashi; M Konishi; H Takahashi; Y Kuroki
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  The alpha-helical neck region of human lung surfactant protein D is essential for the binding of the carbohydrate recognition domains to lipopolysaccharides and phospholipids.

Authors:  U Kishore; J Y Wang; H J Hoppe; K B Reid
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

4.  Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes.

Authors:  Russell P Bowler; Sean Jacobson; Charmion Cruickshank; Grant J Hughes; Charlotte Siska; Daniel S Ory; Irina Petrache; Jean E Schaffer; Nichole Reisdorph; Katerina Kechris
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

5.  N-Glycosylation of Seasonal Influenza Vaccine Hemagglutinins: Implication for Potency Testing and Immune Processing.

Authors:  Yanming An; Lisa M Parsons; Ewa Jankowska; Darya Melnyk; Manju Joshi; John F Cipollo
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

6.  Influenza Virus Hemagglutinins H2, H5, H6, and H11 Are Not Targets of Pulmonary Surfactant Protein D: N-Glycan Subtypes in Host-Pathogen Interactions.

Authors:  Lisa M Parsons; Yanming An; Li Qi; Mitchell R White; Roosmarijn van der Woude; Kevan L Hartshorn; Jeffery K Taubenberger; Robert P de Vries; John F Cipollo
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

Review 7.  Surfactant protein-D and pulmonary host defense.

Authors:  E C Crouch
Journal:  Respir Res       Date:  2000-08-25

8.  Distinct compartmentalization of SP-A and SP-D in the vasculature and lungs of patients with idiopathic pulmonary fibrosis.

Authors:  Hirotaka Nishikiori; Hirofumi Chiba; Shigeru Ariki; Koji Kuronuma; Mitsuo Otsuka; Masanori Shiratori; Kimiyuki Ikeda; Atsushi Watanabe; Yoshio Kuroki; Hiroki Takahashi
Journal:  BMC Pulm Med       Date:  2014-12-08       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.